These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20043321)

  • 1. Technological progresses in monoclonal antibody production systems.
    Rodrigues ME; Costa AR; Henriques M; Azeredo J; Oliveira R
    Biotechnol Prog; 2010; 26(2):332-51. PubMed ID: 20043321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines to cell engineering for monoclonal antibody production.
    Rita Costa A; Elisa Rodrigues M; Henriques M; Azeredo J; Oliveira R
    Eur J Pharm Biopharm; 2010 Feb; 74(2):127-38. PubMed ID: 19853660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upstream processes in antibody production: evaluation of critical parameters.
    Jain E; Kumar A
    Biotechnol Adv; 2008; 26(1):46-72. PubMed ID: 17920803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-use purification process for the production of a monoclonal antibody produced in a PER.C6 human cell line.
    Kuczewski M; Schirmer E; Lain B; Zarbis-Papastoitsis G
    Biotechnol J; 2011 Jan; 6(1):56-65. PubMed ID: 21170980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In pursuit of the optimal fed-batch process for monoclonal antibody production.
    Bibila TA; Robinson DK
    Biotechnol Prog; 1995; 11(1):1-13. PubMed ID: 7765983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody production.
    Birch JR; Racher AJ
    Adv Drug Deliv Rev; 2006 Aug; 58(5-6):671-85. PubMed ID: 16822577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in large-scale production of monoclonal antibodies and related proteins.
    Shukla AA; Thömmes J
    Trends Biotechnol; 2010 May; 28(5):253-61. PubMed ID: 20304511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining process design space for monoclonal antibody cell culture.
    Abu-Absi SF; Yang L; Thompson P; Jiang C; Kandula S; Schilling B; Shukla AA
    Biotechnol Bioeng; 2010 Aug; 106(6):894-905. PubMed ID: 20589669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suspension culture of mammalian cells.
    Birch JR; Arathoon R
    Bioprocess Technol; 1990; 10():251-70. PubMed ID: 1367062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards the implementation of quality by design to the production of therapeutic monoclonal antibodies with desired glycosylation patterns.
    del Val IJ; Kontoravdi C; Nagy JM
    Biotechnol Prog; 2010; 26(6):1505-27. PubMed ID: 20665659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State-of-the-art in downstream processing of monoclonal antibodies: process trends in design and validation.
    Marichal-Gallardo PA; Alvarez MM
    Biotechnol Prog; 2012 Jul; 28(4):899-916. PubMed ID: 22641473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beware the Medical-Industrial Complex.
    Stevens CW; Glatstein E
    Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A predictive high-throughput scale-down model of monoclonal antibody production in CHO cells.
    Legmann R; Schreyer HB; Combs RG; McCormick EL; Russo AP; Rodgers ST
    Biotechnol Bioeng; 2009 Dec; 104(6):1107-20. PubMed ID: 19623562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody expression in mammalian cells.
    Zhang RY; Shen WD
    Methods Mol Biol; 2012; 907():341-58. PubMed ID: 22907362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and optimization of an adenovirus production process.
    Kamen A; Henry O
    J Gene Med; 2004 Feb; 6 Suppl 1():S184-92. PubMed ID: 14978761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Getting higher yields of monoclonal antibody in culture.
    Kundu PK; Prasad NS; Electricwala SE; Varma R; Datta D
    Indian J Physiol Pharmacol; 1998 Apr; 42(2):155-71. PubMed ID: 10225044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal nitrogen supply as a key to increased and sustained production of a monoclonal full-size antibody in BY-2 suspension culture.
    Holland T; Sack M; Rademacher T; Schmale K; Altmann F; Stadlmann J; Fischer R; Hellwig S
    Biotechnol Bioeng; 2010 Oct; 107(2):278-89. PubMed ID: 20506104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals.
    Butler M
    Appl Microbiol Biotechnol; 2005 Aug; 68(3):283-91. PubMed ID: 15834715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Industrial processes with animal cells.
    Kretzmer G
    Appl Microbiol Biotechnol; 2002 Jul; 59(2-3):135-42. PubMed ID: 12111138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
    Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
    J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.